Tamoxifen-loaded solid lipid nanoparticles-induced apoptosis in breast cancer cell lines

39Citations
Citations of this article
60Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

An in vitro study was conducted to determine the apoptosis induced by tamoxifen (TAM) and TAM-loaded solid lipid nanoparticles (SLNs) in breast cancer cell lines, MCF-7 and MDA-MB231 cells. The effect of free drug and drug-loaded SLN on the cell lines was characterised by cell morphology and cell cycle distribution using phase contrast microscopy, nuclear morphology and flow cytometry, respectively. The results showed that TAM-loaded SLNs have an equally efficient cytotoxic activity against MCF-7 and MDA-MB231 cells, compared to free TAM, and the half maximal inhibitory concentration (IC50) of TAM-loaded SLNs was generally lower than that of free TAM. In the presence of TAM and TAM-loaded SLN, the viability of the both cells diminishes and the cancer cells lose their normal morphological characteristics, detaches, aggregates and later develops apoptotic bodies. Flow cytometry analysis showed that TAM-loaded SLN like the free TAM caused a dose- and time-dependent apoptosis without cell cycle arrest of human breast cancer cells. Therefore, TAM-loaded SLN has great potential in human medicine for the treatment of breast cancers.

Cite

CITATION STYLE

APA

Abbasalipourkabir, R., Salehzadeh, A., & Abdullah, R. (2016). Tamoxifen-loaded solid lipid nanoparticles-induced apoptosis in breast cancer cell lines. Journal of Experimental Nanoscience, 11(3), 161–174. https://doi.org/10.1080/17458080.2015.1038660

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free